Advertisement

Topics

Immunovia Sets Up U.S. Base to Commercialize Biomarker Test for Early Pancreatic Cancer

05:12 EDT 30 Jun 2017 | Genetic Engineering News

Swedish molecular diagnostics firm Immunovia has secured a site in Boston, MA, to establish its U.S. headquarters and CLIA-accredited reference laboratory for eastern U.S. The firm is setting up a U.S operation in anticipation of the projected introduction of its array-based IMMray™ PanCan-d serum diagnostic test for early pancreatic cancer to the U.S. market during in the second half of 2018. Immunovia said the Boston site will also house commercialization operations including marketing, sales and customer support.  The company has an existing collaboration with Knight Diagnostic Laboratories in Portland, to serve western U.S. Commenting on setting up is U.S. operational base, Mats Grahn, Immunovia CEO, stated, "The market introduction of IMMray™ PanCan-d, our blood based test for earlier detection of pancreas cancer, is the main focus for Immunovia. We have therefore chosen to establish our USA operations headquarters in Boston, which is the major biotech hub in the ...

Original Article: Immunovia Sets Up U.S. Base to Commercialize Biomarker Test for Early Pancreatic Cancer

NEXT ARTICLE

More From BioPortfolio on "Immunovia Sets Up U.S. Base to Commercialize Biomarker Test for Early Pancreatic Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...